News

Filter

Current filters:

Pulmonology

1 to 9 of 12 results

ERS 2014: Mundipharma reports positive Ph III results for flutiform in pediatric asthma

ERS 2014: Mundipharma reports positive Ph III results for flutiform in pediatric asthma

08-09-2014

UK inhalation drug delivery specialist Skyepharma today announced that data from a randomized, multicenter,…

FlutiformGermanyMundipharmaPharmaceuticalPulmonologyResearchRespiratory and PulmonaryRespiratory therapySkyepharmaUK

ERS 2014: Encouraging new data with AstraZeneca’s benralizumab

ERS 2014: Encouraging new data with AstraZeneca’s benralizumab

08-09-2014

Anglo-Swedish drug major AstraZeneca today announced that The Lancet Respiratory Medicine has published…

AstraZenecabenralizumabBiotechnologyCOPDGermanyHealth Medical PharmaPulmonologyResearchRespiratory and PulmonaryRespiratory therapyUK

FDA approves Boehringer’s Striverdi Respimat for COPD

FDA approves Boehringer’s Striverdi Respimat for COPD

01-08-2014

The US Food and Drug Administration has approved German family-owned pharma major Boehringer Ingelheim’s…

Boehringer IngelheimPharmaceuticalPulmonologyRegulationRespiratory and PulmonaryStriverdi RespimatUSA

GlaxoSmithKline slashes forecast as 2nd-qtr sales and earnings fall sharply

GlaxoSmithKline slashes forecast as 2nd-qtr sales and earnings fall sharply

23-07-2014

UK pharma giant GlaxoSmithKline saw its shares fall 3.9% to £45.94 shortly after the company reported…

FinancialFluticasone propionateGlaxoSmithKlinePharmaceuticalPulmonologyUK

FDA accepts Teva’s NDA for albuterol MDPI

FDA accepts Teva’s NDA for albuterol MDPI

15-07-2014

Israel-based generic giant Teva Pharmaceuticals Industries says that the US Food and Drug Administration…

albuterolExercise-induced bronchospasmGenericsPulmonologyRegulationRespiratory and PulmonaryTeva Pharmaceutical IndustriesUSA

US FDA approves GSK’s Incruse Ellipta for COPD

US FDA approves GSK’s Incruse Ellipta for COPD

01-05-2014

The US Food and Drug Administration has approved UK pharma major GlaxoSmithKline’s Incruse (umeclidinium)…

Chronic lower respiratory diseasesCOPDGlaxoSmithKlineIncruseIncruse ElliptaMajorMedicinePharmaceuticalPulmonologyRegulationRespiratory and PulmonaryUKUSA

1 to 9 of 12 results

Back to top